US Stock MarketDetailed Quotes

XTLB XTL Biopharmaceuticals

Watchlist

2.660
-0.140-5.00%

Close May 22 16:00 ET

2.820
+0.160+6.01%

Pre 04:01 ET

14.50MMarket Cap-85809P/E (TTM)

XTL Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-18.67%2.34M

-46.09%2.01M

-49.72%2.21M

-53.78%2.38M

3.01%2.88M

-39.27%3.72M

45.70%4.39M

-18.12%5.16M

-Cash and cash equivalents

-43.91%1.07M

-33.09%1.4M

-34.55%1.46M

-32.27%1.59M

-31.81%1.9M

-29.47%2.09M

-26.07%2.23M

-19.60%2.35M

-Short-term investments

30.76%1.27M

-62.81%605K

-65.34%749K

-71.74%794K

--972K

-48.48%1.63M

--2.16M

-16.84%2.81M

Receivables

--150K

-59.15%29K

----

--71K

----

-Loans receivable

--150K

----

-Other receivables

----

-59.15%29K

----

--71K

----

Other current assets

-10.61%59K

-21.43%11K

-40.77%77K

-46.36%118K

-98.09%66K

-12.50%14K

-96.24%130K

-19.71%220K

Total current assets

-13.39%2.55M

-46.24%2.05M

-49.46%2.28M

-53.48%2.5M

-52.85%2.94M

-38.98%3.81M

-30.22%4.52M

-18.19%5.38M

Non current assets

Net PPE

----

--0

-50.00%1K

Goodwill and other intangible assets

0.00%380K

--380K

0.00%380K

--380K

0.00%380K

-Other intangible assets

----

0.00%380K

----

0.00%380K

----

Total non current assets

0.00%380K

-0.26%380K

-0.52%380K

-0.26%381K

Total assets

-11.86%2.93M

-42.04%2.43M

-45.62%2.66M

-49.96%2.88M

-49.83%3.32M

-36.75%4.19M

-28.56%4.9M

-17.20%5.76M

Liabilities

Current liabilities

Payables

-7.47%223K

-50.00%1K

--162K

--163K

--241K

0.00%2K

----

-accounts payable

-7.47%223K

-50.00%1K

--162K

--163K

--241K

0.00%2K

----

Current accrued expenses

----

10.81%205K

----

-19.21%185K

----

Current liabilities

-7.47%223K

10.16%206K

5.88%162K

-5.23%163K

-7.31%241K

-19.05%187K

-17.30%153K

-33.33%172K

Non current liabilities

Derivative product liabilities

----

--0

-99.36%22K

Total non current liabilities

--0

-99.36%22K

Total liabilities

-7.47%223K

10.16%206K

5.88%162K

-15.98%163K

-68.98%241K

-85.45%187K

-95.95%153K

-94.72%194K

Shareholders'equity

Share capital

0.00%14.12M

--14.12M

0.00%14.12M

--14.12M

3.80%14.12M

-common stock

0.00%14.12M

--14.12M

0.00%14.12M

--14.12M

3.80%14.12M

Retained earnings

-0.24%-157.76M

-1.14%-158.25M

-1.44%-157.97M

-1.84%-157.75M

---157.39M

-0.86%-156.47M

---155.72M

0.99%-154.9M

Paid-in capital

0.00%146.33M

--146.33M

0.00%146.33M

--146.33M

0.15%146.33M

Gains losses not affecting retained earnings

0.00%20K

--20K

0.00%20K

--20K

0.00%20K

Total stockholders'equity

-12.20%2.71M

-44.49%2.22M

-47.28%2.5M

-51.14%2.72M

-47.28%3.08M

-25.01%4M

54.08%4.74M

69.50%5.56M

Total equity

-12.20%2.71M

-44.49%2.22M

-47.28%2.5M

-51.14%2.72M

-47.28%3.08M

-25.01%4M

54.08%4.74M

69.50%5.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-18.67%2.34M	-46.09%2.01M	-46.09%2.01M	-49.72%2.21M	-53.78%2.38M	3.01%2.88M	-39.27%3.72M	-39.27%3.72M	45.70%4.39M	-18.12%5.16M
-Cash and cash equivalents	-43.91%1.07M	-33.09%1.4M	-33.09%1.4M	-34.55%1.46M	-32.27%1.59M	-31.81%1.9M	-29.47%2.09M	-29.47%2.09M	-26.07%2.23M	-19.60%2.35M
-Short-term investments	30.76%1.27M	-62.81%605K	-62.81%605K	-65.34%749K	-71.74%794K	--972K	-48.48%1.63M	-48.48%1.63M	--2.16M	-16.84%2.81M
Receivables	--150K	-59.15%29K	-59.15%29K	----	----	----	--71K	--71K	----	----
-Loans receivable	--150K	----	----	----	----	----	----	----	----	----
-Other receivables	----	-59.15%29K	-59.15%29K	----	----	----	--71K	--71K	----	----
Other current assets	-10.61%59K	-21.43%11K	-21.43%11K	-40.77%77K	-46.36%118K	-98.09%66K	-12.50%14K	-12.50%14K	-96.24%130K	-19.71%220K
Total current assets	-13.39%2.55M	-46.24%2.05M	-46.24%2.05M	-49.46%2.28M	-53.48%2.5M	-52.85%2.94M	-38.98%3.81M	-38.98%3.81M	-30.22%4.52M	-18.19%5.38M
Non current assets
Net PPE	----	----	----	----	----	----	----	----	--0	-50.00%1K
Goodwill and other intangible assets	0.00%380K	0.00%380K	0.00%380K	0.00%380K	0.00%380K	--380K	0.00%380K	0.00%380K	--380K	0.00%380K
-Other intangible assets	----	0.00%380K	0.00%380K	----	----	----	0.00%380K	0.00%380K	----	----
Total non current assets	0.00%380K	0.00%380K	0.00%380K	0.00%380K	-0.26%380K	-0.26%380K	-0.26%380K	-0.26%380K	-0.52%380K	-0.26%381K
Total assets	-11.86%2.93M	-42.04%2.43M	-42.04%2.43M	-45.62%2.66M	-49.96%2.88M	-49.83%3.32M	-36.75%4.19M	-36.75%4.19M	-28.56%4.9M	-17.20%5.76M
Liabilities
Current liabilities
Payables	-7.47%223K	-50.00%1K	-50.00%1K	--162K	--163K	--241K	0.00%2K	0.00%2K	----	----
-accounts payable	-7.47%223K	-50.00%1K	-50.00%1K	--162K	--163K	--241K	0.00%2K	0.00%2K	----	----
Current accrued expenses	----	10.81%205K	10.81%205K	----	----	----	-19.21%185K	-19.21%185K	----	----
Current liabilities	-7.47%223K	10.16%206K	10.16%206K	5.88%162K	-5.23%163K	-7.31%241K	-19.05%187K	-19.05%187K	-17.30%153K	-33.33%172K
Non current liabilities
Derivative product liabilities	----	----	----	----	----	----	----	----	--0	-99.36%22K
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	-99.36%22K
Total liabilities	-7.47%223K	10.16%206K	10.16%206K	5.88%162K	-15.98%163K	-68.98%241K	-85.45%187K	-85.45%187K	-95.95%153K	-94.72%194K
Shareholders'equity
Share capital	0.00%14.12M	0.00%14.12M	0.00%14.12M	0.00%14.12M	0.00%14.12M	--14.12M	0.00%14.12M	0.00%14.12M	--14.12M	3.80%14.12M
-common stock	0.00%14.12M	0.00%14.12M	0.00%14.12M	0.00%14.12M	0.00%14.12M	--14.12M	0.00%14.12M	0.00%14.12M	--14.12M	3.80%14.12M
Retained earnings	-0.24%-157.76M	-1.14%-158.25M	-1.14%-158.25M	-1.44%-157.97M	-1.84%-157.75M	---157.39M	-0.86%-156.47M	-0.86%-156.47M	---155.72M	0.99%-154.9M
Paid-in capital	0.00%146.33M	0.00%146.33M	0.00%146.33M	0.00%146.33M	0.00%146.33M	--146.33M	0.00%146.33M	0.00%146.33M	--146.33M	0.15%146.33M
Gains losses not affecting retained earnings	0.00%20K	0.00%20K	0.00%20K	0.00%20K	0.00%20K	--20K	0.00%20K	0.00%20K	--20K	0.00%20K
Total stockholders'equity	-12.20%2.71M	-44.49%2.22M	-44.49%2.22M	-47.28%2.5M	-51.14%2.72M	-47.28%3.08M	-25.01%4M	-25.01%4M	54.08%4.74M	69.50%5.56M
Total equity	-12.20%2.71M	-44.49%2.22M	-44.49%2.22M	-47.28%2.5M	-51.14%2.72M	-47.28%3.08M	-25.01%4M	-25.01%4M	54.08%4.74M	69.50%5.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall